Just posted this morning at Rx Investors:
Why Subscribe to Rx Investors:
- In-Depth Research
- Objective Opinion
- Clear & Concise Buy / Sell Recommendations
- Excellent Results: 42 out of 52 (81%) Buy Recommendations have been closed with a profit since March 12, 2010.
Succeed. Subscribe Today!
Annual Premium PLUS Subscription $200
Annual Premium Subscription: $75
Disclosure: No positions.